| WB | 咨询技术 | Human,Mouse,Rat |
| IF | 咨询技术 | Human,Mouse,Rat |
| IHC | 1/25-1/50 | Human,Mouse,Rat |
| ICC | 技术咨询 | Human,Mouse,Rat |
| FCM | 咨询技术 | Human,Mouse,Rat |
| Elisa | 咨询技术 | Human,Mouse,Rat |
| Aliases | CPT1; IIAE4; CPTASE |
| Entrez GeneID | 1376; |
| WB Predicted band size | 74kDa |
| Host/Isotype | Rabbit IgG |
| Antibody Type | Primary antibody |
| Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| Species Reactivity | Human,Mouse,Rat |
| Immunogen | Synthetic peptide corresponding to a region derived from internal residues of human Carnitine palmitoyltransferase 2 |
| Formulation | Purified antibody in PBS with 0.05% sodium azide. |
+ +
以下是基于真实研究的示例参考文献格式，供参考。由于文献的具体内容可能因数据库访问权限而有所不同，建议通过学术平台(如PubMed、Google Scholar)进一步验证：
---
1. **"Monoclonal antibodies against human carnitine palmitoyltransferase II: Novel tools for studies on fatty acid metabolism"**
*作者：Yamaguchi, M., et al. (1996)*
**摘要**：该研究开发了针对人CPT2的单克隆抗体，验证了其在免疫印迹(Western blot)和免疫细胞化学中的应用，证实了CPT2在线粒体脂肪酸氧化中的关键作用。
2. **"Diagnosis of carnitine palmitoyltransferase II deficiency by monoclonal antibody-based enzyme assay"**
*作者：Taroni, F., et al. (1993)*
**摘要**：通过基于单克隆抗体的酶免疫分析，提出了一种快速诊断CPT2缺陷症的方法，为临床检测提供了可靠工具。
3. **"Tissue-specific expression of CPT2 in human skeletal muscle and liver revealed by immunohistochemistry"**
*作者：Bonnefont, J.P., et al. (1990)*
**摘要**：利用多克隆抗体进行免疫组化分析，揭示了CPT2在肌肉和肝脏中的特异性表达模式，支持其在能量代谢中的组织特异性功能。
4. **"Validation of CPT2 antibody for mitochondrial protein quantification in metabolic disorders"**
*作者：Wieser, T., et al. (2003)*
**摘要**：验证了CPT2抗体在患者样本中的定量应用，强调了其在代谢疾病研究中的诊断价值。
---
**注意**：以上文献标题及内容为示例性质，具体细节需通过学术数据库核实。建议使用关键词 **“CPT2 antibody” + “diagnosis”/“Western blot”/“immunohistochemistry”** 进行精准检索。
Carnitine palmitoyltransferase 2 (CPT2) is a mitochondrial enzyme critical for fatty acid β-oxidation, enabling the transport of long-chain fatty acids into the mitochondrial matrix for energy production. Located on the inner mitochondrial membrane, CPT2 catalyzes the conversion of acylcarnitines back to acyl-CoA esters, a step essential for lipid metabolism. Dysfunction in CPT2. caused by genetic mutations, leads to CPT2 deficiency—a rare autosomal recessive disorder associated with life-threatening metabolic crises, muscle weakness, and hepatocardiac complications.
CPT2 antibodies are immunological tools designed to detect and quantify CPT2 protein expression in research and diagnostics. These antibodies are widely used in Western blotting, immunohistochemistry (IHC), and immunofluorescence (IF) to study CPT2’s tissue distribution, expression levels under metabolic stress (e.g., fasting or disease), and its role in pathologies like obesity, diabetes, and cancer. Monoclonal and polyclonal CPT2 antibodies are developed using epitopes from conserved regions of the human CPT2 protein, ensuring specificity across experimental models.
In clinical settings, CPT2 antibodies aid in confirming CPT2 deficiency diagnoses by identifying reduced enzyme levels in patient samples. Researchers also leverage these antibodies to explore therapeutic strategies targeting fatty acid metabolism, emphasizing their dual utility in advancing both basic science and translational medicine.
×
